Search clinical trials for: Trafermin (genetical recombination)

Total 5661 results

Kaken Pharmaceutical

Completed

A Phase2 Clinical Trial of Trafermin in Patients With Marginal Periodontitis in Japan

Periodontitis

Japan
Kaken Pharmaceutical

Completed

Phase 3 Clinical Trial of Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2(Trafermin)

Periodontitis | Alveolar Bone Loss | Periodontal Attachment Loss

Japan
Kaken Pharmaceutical

Completed

Trial in Periodontal Tissue Regeneration Using Fibroblast Growth Factor-2

Periodontitis
Pfizer

Completed

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Hemophilia B

Japan
International University of Health and Welfare
Japan Agency for Medical Research and Development; Chugai Pharmaceutical; Keio...

Recruiting

Satralizumab in the Treatment of Pulmonary Arterial Hypertension (SATISFY-JP Trial)

Pulmonary Arterial Hypertension

Japan
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Northern Europe The TRANS-North Study (TRANS-North)

Diabetic Foot Ulcer of Neuropathic Origin

Belgium, Germany, Poland, Croatia, Bulgaria, Denmark, Slovakia, Hungary, Netherlands, Sweden
Olympus Biotech Corporation

Completed

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study (TRANS-South)

Diabetic Foot Ulcer of Neuropathic Origin

France, Italy, Hungary, Czech Republic
Kaken Pharmaceutical

Completed

A Study to Assess the Safety of Using Fibroblast Growth Factor-2 With Periodontal Surgery in Japan (Phase 3)

Periodontitis

Japan
Nordisk Rebalance A/S
Hvidovre University Hospital

Completed

Profermin® in Active Ulcerative Colitis (CUPE-1)

Ulcerative Colitis
Nordisk Rebalance A/S
Hvidovre University Hospital

Completed

Trial on Profermin and Fresubin in Ulcerative Colitis (CUPE2)

Ulcerative Colitis

Denmark
Unity Health Toronto

Active, not recruiting

Genetics Adviser: Evaluating a Digital Decision Support Tool for Genetic Results

Cancer

Canada
Takeda

Recruiting

Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Crohn's Disease]

Crohn's Disease

Japan
University of Michigan Rogel Cancer Center
National Cancer Institute (NCI)

Recruiting

Methods for Increasing Genetic Testing Uptake in Michigan (MiGHT)

Breast Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | History of Cancer

United States
Case Comprehensive Cancer Center

Recruiting

Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer

Breast Cancer

United States
Nagoya University
Japan Agency for Medical Research and Development; Zenyaku Kogyo Co., Ltd.

Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies (RECIPE)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Japan
Shoichi Maruyama MD PhD

Recruiting

Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic Syndrome (PRIME)

Glomerulonephritis, Membranous | Nephrotic Syndrome，Idiopathic

Japan
Eurofarma Laboratorios S.A.

Completed

Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL) (GLACIAL)

Osteoarthritis of Knee

Brazil
Nordisk Rebalance A/S
Linkoeping University; University Hospital, Linkoeping

Completed

Effect of Postbiotic Product on Colonic Barriers in IBS

IBS - Irritable Bowel Syndrome

Sweden
Oslo University Hospital
Danish Pain Research Center; University Hospital of North Norway; University... and other collaborators

Recruiting

Exploring the Genetics of Neuropathic Pain (GeNeup)

Neuropathic Pain | Polyneuropathies | Genetic Predisposition

Norway
Takeda

Completed

Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

Untreated CD30-Positive Hodgkin's Lymphoma

Japan
Takeda

Completed

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Peripheral T Cell Lymphoma | Pediatric Hodgkin Lymphoma

Japan
Emory University

Completed

Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer

Hereditary Breast and Ovarian Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Malignant Solid Neoplasm | Breast Carcinoma | Digestive System Neoplasm | Skin Carcinoma | Malignant Female Reproductive System Neoplasm | Metastatic Malignant Neoplasm of Unknown Primary | Malignant Head and Neck Neoplasm | Malignant Brain Neoplasm | Malignant Central Nervous System Neoplasm | Malignant... and other conditions

United States
Odense University Hospital
University of Southern Denmark; Region of Southern Denmark; Odense Patient Data... and other collaborators

Active, not recruiting

Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota (SYN-ALD)

Probiotics | Liver Fibrosis | Alcoholic Liver Disease | Liver Cirrhosis, Alcoholic

Denmark
Ohio State University Comprehensive Cancer Center

Active, not recruiting

Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care (OPTEC)

Lynch Syndrome | Relatives | Endometrial Carcinoma | Endometrial Adenocarcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); Oregon Health and Science University

Recruiting

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Malignant Solid Neoplasm | Lynch Syndrome | Hematopoietic and Lymphoid System Neoplasm | Breast Ductal Carcinoma In Situ | Hereditary Neoplastic Syndrome | BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome

United States
Augusta University

Recruiting

Genetic Testing in African Americans (GTM-I)

Ovarian Cancer | Endometrial Cancer | Peritoneal Cancer

United States
Thomas Jefferson University
Prostate Cancer Foundation

Active, not recruiting

Technology-Enhanced Acceleration of Germline Evaluation for Therapy, TARGET Study

Biochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Terminated

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage III Colon Cancer AJCC v8 | Stage III Rectal Cancer AJCC v8 | Stage IIIA Colon Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Colon Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Colon Cancer AJCC... and other conditions

United States
Adaptimmune
GOG Foundation

Recruiting

ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3)

Ovarian Cancer

United States, Spain, France, Canada, United Kingdom
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Completed

Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients With Advanced Cancer

Advanced Malignant Neoplasm | Locally Advanced Malignant Neoplasm

United States
Mayo Clinic
National Cancer Institute (NCI)

Recruiting

Cancer Genetic Testing in Ethnic Populations

Malignant Solid Neoplasm | Breast Carcinoma | Digestive System Carcinoma | Head and Neck Carcinoma | Skin Carcinoma | Malignant Female Reproductive System Neoplasm | Malignant Brain Neoplasm | Carcinoma of Unknown Primary | Central Nervous System Carcinoma | Genitourinary System Carcinoma | Malignant Musculoskeletal...

United States
University of Washington
National Cancer Institute (NCI)

Active, not recruiting

Genetic Testing for Men With Metastatic Prostate Cancer (GENTleMEN)

Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Dana-Farber Cancer Institute
Myriad Genetics, Inc.

Active, not recruiting

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Breast Cancer | Invasive Breast Cancer | Genetic Testing | in Situ Breast Cancer

United States
Kaiser Permanente
Dana-Farber Cancer Institute; Columbia University; Emory University; University... and other collaborators

Active, not recruiting

Cancer Health Assessments Reaching Many (CHARM)

Hereditary Cancer Syndrome

United States
VA Office of Research and Development

Completed

Evaluation of Videoconferencing Versus Telephone Genetic Counseling (EVTGC)

Remote Consultation, Teleconsultation | Remote Consultation, Video

United States
McGill University Health Centre/Research Institute...

Recruiting

Translational-Omics in Aortic Stenosis (TOmAS) Biobank

Cardiovascular Diseases | Aortic Valve Stenosis

Canada
Pfizer

Completed

Enbrel-Juvenile Idiopathic Arthritis (JIA) Use Results Survey [All-Case Surveillance] (Enbrel-JIA)

Juvenile Idiopathic Arthritis

Japan
Assistance Publique - Hôpitaux de Paris

Completed

Cancer and Hearing Loss Related in Children (OTOPLAT)

Hearing Loss | Cancer in Children

France
Icahn School of Medicine at Mount Sinai

Completed

Genetic Testing to Understand and Address Renal Disease Disparities (GUARDD)

Hypertension | Chronic Kidney Disease | Genomics

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | Melanoma | Sarcoma

United States
University of Utah
National Cancer Institute (NCI)

Completed

Risk Education and Assessment for Cancer Heredity (REACH)

Breast Cancer | Ovarian Cancer | Genetic Predisposition

United States
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding of Genetic Risk Information for Type 2 Diabetes

Diabetes Mellitus, Type 2

United States
Charite University, Berlin, Germany

Unknown

Long Time Metabolic Changes Induced by Genetically Modified Potatoes

Glucose Metabolism | Satiety | Hormonal Changes

Germany
Northwestern University

Completed

Genetics of Familial and Sporadic ALS (ALS)

Amyotrophic Lateral Sclerosis (ALS) | Lou Gehrig's Disease | Primary Lateral Sclerosis (PLS) | Familial Amyotrophic Lateral Sclerosis | ALS With Frontotemporal Dementia (ALS/FTD) | Motor Neuron Disease (MND) | Sporadic ALS (SALS)

United States
University of Virginia

Not yet recruiting

Genetic Information Assistant in Telegenetics

Genetic Predisposition | Gene Mutation-Related Cancer
The University of Hong Kong

Recruiting

Intervention Study: Genetic Risk Communication and Wearables

Type 2 Diabetes | Genetic Predisposition to Disease | Exercise | Sedentary Behavior | Fitness Trackers

Hong Kong
The University of Hong Kong

Active, not recruiting

Full-scale Intervention Study: Genetic Risk Communication and Wearables

Physical Activity | Type 2 Diabetes | Genetic Predisposition to Disease | Exercise | Fitness Trackers

Hong Kong
Philipps University Marburg Medical Center

Completed

Evaluation of Consultation Including Genetic Aspects of Obesity

Obesity

Search clinical trials for: Trafermin (genetical recombination)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations